Mannkind won at today's Adcom!

I'm wrong to bet against Mannkind. At today's Adcom, Mannkin's Afrezza got the advisory board support for a recommendation for approval. While the FDA is not required to follow the recommendation, it often does. But the final say is always at the hands of the FDA. The decision is expected on Apr 15. We will see in less than 2 weeks.